Boehringer Ingelheim Pharmaceucticals is categorized under Drugs, Proprietaries, and Sundries in Charlotte, NC and active since 2010.
Boehringer Ingelheim Pharmaceucticals was established in 2010, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Drugs, Proprietaries, and Sundries business, which does work in the B2C market, and is classified as a Drugs, Proprietaries, and Sundries, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Elizabeth Smith at the company’s single location by writing to 2722 Briarcliff Place, Charlotte, North Carolina NC 28207 or by phoning (704) 375-3250. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Boehringer Ingelheim Pharmaceucticals |
| Contact Person: | Elizabeth Smith |
| Address: | 2722 Briarcliff Place, Charlotte, North Carolina 28207 |
| Phone Number: | (704) 375-3250 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Drugs, Proprietaries, and Sundries |
| SIC Code: | 5122 |
| NAICS Code: | 424210 |
| Share This Business: |
Boehringer Ingelheim Pharmaceucticals was started in 2010 to provide professional Drugs, Proprietaries, and Sundries under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Elizabeth Smith for inquiries that concern Boehringer Ingelheim Pharmaceucticals by calling the company number (704) 375-3250, as your correspondence is most welcome. Additionally, the physical location of the single location of Boehringer Ingelheim Pharmaceucticals can be found at the coordinates 35.183637,-80.828388 as well as the street address 2722 Briarcliff Place in Charlotte, North Carolina 28207.
For its online presence, you may visit Boehringer Ingelheim Pharmaceucticals’s website at and engage with its social media outlets through on Twitter and on Facebook.